Kim Midwood is Professor of Matrix Biology at Oxford University, and Principal Investigator at the Kennedy Institute of Rheumatology, studying how the cellular microenvironment drives, and shapes, immune responses.
Kim graduated with a B.Sc. (HONS) in Biochemistry from Edinburgh University in 1995, and completed her Ph.D. in the Department of Pathology at Edinburgh University in 1999, identifying how changes in the extracellular matrix switch cell signalling pathways in arthritis. She undertook postdoctoral training in the Department of Molecular Biology at Princeton University in the US from 1999, investigating the molecular mechanisms by which environmental cues define cell phenotype. In 2004 she established the Matrix Immunology group in the Kennedy Institute of Rheumatology at Imperial College London to examine how immunomodulatory matrix molecules contribute to healthy innate immune responses, and their role in pathological inflammation, moving to Oxford University in 2011. In 2007 she was awarded an MRC New Investigators Award and in 2012 an Arthritis Research UK Senior Fellowship. She founded the BioTech company Nascient Ltd in 2012